Try our Advanced Search for more refined results
FTC v. Boehringer Ingelheim Pharmace
Case Number:
12-5393
Court:
Nature of Suit:
Companies
Government Agencies
Sectors & Industries:
-
April 07, 2015
Boehringer Asks DC Circ. To Rethink Doc Ruling In FTC Probe
Boehringer Ingelheim Pharmaceuticals Inc. asked the D.C. Circuit on Monday for another shot at defending a lower court order that largely rejected the Federal Trade Commission's documents request in its investigation into an alleged Aggrenox pay-for-delay deal, arguing the circuit court's ruling slashed work product protections.
-
September 12, 2013
FTC Wants Access To Boehringer Docs In Pay-For-Delay Probe
The Federal Trade Commission told the D.C. Circuit on Wednesday that it should force Boehringer Ingelheim Pharmaceuticals Inc. to turn over documents about a $100 million drug co-promotion deal with Barr Pharmaceuticals Inc., saying the information could indicate an unlawful pay-for-delay agreement.